Feasibility of a Supported Walking Program for Breast and Head-and-Neck Cancer Survivors Receiving Adjuvant Radiation Therapy
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Physical Activity
- Sponsor
- University of Alberta
- Enrollment
- 21
- Locations
- 1
- Primary Endpoint
- Accrual Rate and Completion Rate
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
This pilot study will assess whether a supported pedometer-based walking program is helpful in maintaining physical activity for breast and head-and-neck cancer patients who are undergoing radiation therapy. Follow-up monitoring sessions will be scheduled to help provide support for physical activity during radiation therapy. We will also examine the relationship of physical activity and quality of life outcomes to help inform future research.
Detailed Description
Will the integration of a patient-centered exercise prescription and supportive counseling attenuate declines in physical activity during radiation therapy? To address this question, this study will assess the feasibility of a patient-centered walking program for breast and head-and-neck cancer patients undergoing radiation therapy. Follow-up monitoring sessions will be scheduled to help provide support and ongoing counseling to facilitate increased activity (through walking) during radiation therapy. We will also examine the effect of the walking program on other outcomes such as happiness, depression and sleep to determine point estimates and measures of variability to inform future research.
Investigators
Margie McNeely
Assistant Professor
University of Alberta
Eligibility Criteria
Inclusion Criteria
- •Survivors with a diagnosis of breast cancer or head and neck cancer
- •Adults aged 18 years or older
- •Commencing adjuvant radiation therapy treatments
- •Karnofsky Performance Status greater than or equal to 60%
Exclusion Criteria
- •Clinical or radiological evidence of active disease, either local or metastatic
- •Serious non-malignant disease, such as cardiac failure or advanced arthritis of weight bearing joints, which would preclude daily treatment and follow-up
- •Patients for whom physical activity or exercise is contraindicated
- •Psychiatric or addictive disorders which preclude obtaining informed consent or adherence to the protocol
- •Unable to comply with the protocol, measurement and follow-up schedule (e.g., scheduling conflicts, time commitment)
Outcomes
Primary Outcomes
Accrual Rate and Completion Rate
Time Frame: Anticipated duration of radiation therapy of 6 weeks
Accrual: Number of participants agreeing to participate divided by the number of eligible participants Completion rate: number of participants completing the trial
Secondary Outcomes
- Adherence(Anticipated duration of radiation therapy of 6 weeks)